American Association for Cancer Research

Marker may predict breast cancer response to tamoxifen

The presence of lower-than-normal amounts of the protein TGFBR2 was associated with breast cancer resistance to treatment with the antiestrogen therapeutic tamoxifen, according to a study published in Cancer Research, a jour ...

Apr 02, 2015
popularity 27 comments 0

Researchers to present progression-free survival results

Results from the final analysis of progression-free survival, response rate, and safety for the randomized, phase III Breast Cancer Trials of Oral Everolimus-1 (BOLERO-1) are to be presented here at the 2014 San Antonio Breast ...

Dec 15, 2014
popularity 0 comments 0